Human RELT/TNFRSF19L Antibody, R&D Systems™

RELT/TNFRSF19L

Monoclonal

LYOPH

Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready

Q969Z4

RELT

Mouse myeloma cell line NS0-derived recombinant human RELT/TNFRSF19L Met1-Ala160 (Arg127Gly, Arg129Gly) Accession # Q969Z4

25 μg

Primary

Detects human RELT/TNFRSF19L in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) 4-1BB, recombinant mouse (rm) 4-1BB, rhBAFF R, rmBAFF R, rhCD27, rmCD27, rhCD30, rmCD30, rhCD40, rmCD40, rhDR3, rmDR3, rhDR6, rhEDAR, rmEDAR, rhFas, rmFas, rrFas, rhGITR, rmGITR, rhHVEM, rhLT beta R, rmLT beta R, rhNGF R, rmNGF R, rhOPG, rmOPG, rmOX40, rhRANK, rmRANK, rhTNF RI, rmTNF RI, rhTNF RII, rmTNF RII, rhTRAIL R1, rhTRAIL R2, rhTRAIL R3, rhTRAIL R4, rhTROY, or rmTROY is observed.

Human

Purified

Flow Cytometry, CyTOF

238104

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

Receptor expressed in lymphoid tissues, RELT tumor necrosis factor receptor, TNFRSF19L, TNFRSF19LFLJ14993, tumor necrosis factor receptor superfamily member 19L, tumor necrosis factor receptor superfamily, member 19-like

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

84957

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG2b